Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (33 ops.)
Latest filing published 01 Oct 2026 for ORACLE CORP, €3.1M.
Filing timeline
BuySaleStephen H. Rusckowski
Insider track record
Disclosed buys
1
Disclosed sells
33
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Stephen H. Rusckowski: trading record in brief
Stephen H. Rusckowski, Chairman, CEO and President of Quest Diagnostics Inc (99 filings), also serves as a Director at Xerox Corp (5), Tenet Healthcare Corp (3), Baxter International Inc (3) and Oracle Corp (1). The record has 111 filings between January 19, 2016 and October 1, 2026. The 33 sales, all at Quest Diagnostics Inc, weigh EUR 178.6 million, with a median of EUR 897,415; the largest are from October 16, 2020 (EUR 29,930,160), June 13, 2019 (EUR 21,680,442) and May 24, 2022 (EUR 20,396,016).
The single purchase is the most recent event in the record: EUR 3,063,654 at Oracle Corp, on September 29, 2026. It makes up 3% of market trades and is the only filing in the last 12 months. Grants number 55 and option exercises 22.
The yearly volume peaks in 2022 (25 filings) and falls to 1 in 2024, 2 in 2025 and 1 in 2026. At Quest Diagnostics Inc, 22 of Rusckowski's trades are within 30 days of a trade by Michael E. Prevoznik, all in the same direction.
Companies and markets linked to Stephen H. Rusckowski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations111 total
25,000 shares@ US$139.352100.0% of flowCommon StockSEC:0001341439-26-000099:0
Canonical exit: 28 Dec 2026 (T+90)
1,551 sharesCommon StockSEC:0000950170-25-078022:0
7,183 shares0Common Stock, $1 par valueSEC:0001062993-25-008901:0
5,952 shares0Common Stock, $1 par valueSEC:0001062993-24-009783:0
3,049 shares0Common Stock, $1 par valueSEC:0001062993-23-017016:0
3,682 shares0Common StockSEC:0001209191-23-039557:0
2,846 shares0Common StockSEC:0001209191-23-032958:0
38,604 shares@ US$147.861.5% of flowCommon StockSEC:0001022079-23-000064:1
82,631 shares@ US$147.8630.1% of flowCommon StockSEC:0001022079-23-000064:0
3,496 shares@ US$140.691.2% of flowCommon StockSEC:0001022079-23-000052:0
20,059 shares0Common StockSEC:0001022079-23-000037:1
5,826 shares@ US$147.862.1% of flowCommon StockSEC:0001022079-23-000037:0
6,821 shares@ US$140.600.3% of flowCommon StockSEC:0001022079-22-000104:1
2,565 shares@ US$141.360.1% of flowCommon StockSEC:0001022079-22-000104:2
651 shares@ US$142.150.0% of flowCommon StockSEC:0001022079-22-000104:3
14,854 shares@ US$86.630.3% of flowCommon StockSEC:0001022079-22-000104:4
9,823 shares@ US$140.580.4% of flowCommon StockSEC:0001022079-22-000104:5
4,131 shares@ US$141.350.2% of flowCommon StockSEC:0001022079-22-000104:6
900 shares@ US$142.130.0% of flowCommon StockSEC:0001022079-22-000104:7
10,037 shares@ US$103.572.5% of flowCommon StockSEC:0001022079-22-000104:0
33,898 shares@ US$140.121.3% of flowCommon StockSEC:0001022079-22-000102:1
800 shares@ US$141.540.0% of flowCommon StockSEC:0001022079-22-000102:2
200 shares@ US$142.260.0% of flowCommon StockSEC:0001022079-22-000102:3
42,568 shares@ US$86.631.0% of flowCommon StockSEC:0001022079-22-000102:4
41,268 shares@ US$140.121.5% of flowCommon StockSEC:0001022079-22-000102:5
25 of 111 declarations
